Basic Information
Basic information for LINC00662-224-11aa-1
Peptide Name LINC00662-224-11aa-1
Genome Position chr19:27732910-27732942[-]
Species Human
Peptide Sequence MLCGVWIHLTD
Peptide Length 11
Unique No (LINC00662-201-11aa-1,LINC00662-205-11aa,LINC00662-207-11aa,LINC00662-212-11aa,LINC00662-213-11aa-1,LINC00662-214-11aa-1,LINC00662-215-11aa-1,LINC00662-216-11aa-3,LINC00662-217-11aa,LINC00662-219-11aa-2,LINC00662-220-11aa,LINC00662-221-11aa-1,LINC00662-222-11aa,LINC00662-223-11aa-1,LINC00662-225-11aa-1,LINC00662-227-11aa,LINC00662-230-11aa-1,LINC00662-231-11aa-4,LINC00662-232-11aa,LINC00662-233-11aa-1,LINC00662-235-11aa,LINC00662-239-11aa,LINC00662-240-11aa-2,LINC00662-241-11aa,LINC00662-242-11aa-2,LINC00662-244-11aa,LINC00662-245-11aa-1,LINC00662-247-11aa-2,LINC00662-249-11aa-2,LINC00662-251-11aa-2,LINC00662-252-11aa,LINC00662-253-11aa,LINC00662-254-11aa,LINC00662-256-11aa,LINC00662-257-11aa-1,LINC00662-258-11aa-1,LINC00662-259-11aa-2,LINC00662-260-11aa,LINC00662-261-11aa-1,LINC00662-262-11aa-1,LINC00662-264-11aa,LINC00662-265-11aa,LINC00662-267-11aa,LINC00662-268-11aa-1,LINC00662-269-11aa,LINC00662-270-11aa-1,LINC00662-271-11aa,LINC00662-272-11aa,LINC00662-273-11aa-1,LINC00662-274-11aa,LINC00662-275-11aa-2,LINC00662-277-11aa-1)
Grand Average of Hydropathicity 1.0909
Relative Molecular Mass 1467.74
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000656170;LINC00662-224
Transcript Length 2643
Coding Ability 0.3485
DNA Sequence Corresponding to Peptide ATGCTTTGTGGTGTATGGATTCATCTCACTGAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :